Podcasts about ischemic stroke

Send us a textIn this episode of MedStar Health DocTalk, host Debra Schindler speaks with Dr. Othman Abdul-Malak, MD, MSC, a vascular expert, to break down the what carotid artery disease is, and how it can lead to stroke, mini-strokes (TIAs), and sudden vision loss. Learn how to recognize early warning signs—like facial droop, arm weakness, or sudden speech problems—and why acting fast can save brain function. Dr. Abdul-Malak also explains:·       The difference between ischemic and embolic strokes·       What amaurosis fugax means ·       Why age, heart disease, and cholesterol put you at greater risk·       When NOT to take aspirinThis episode is a must-listen for anyone interested in stroke prevention, vascular health, or caring for aging loved ones. Time is brain. Know the signs. Act fast.Subscribe for more expert-led episodes.To make an appointment with Dr. Abdul Malak, call 443-777-1900. If you would like to provide feedback on this podcast or get more information when carotid artery disease or treatment options, send me an to DocTalk@medstar.net For more episodes of MedStar Health DocTalk, go to medstarhealth.org/doctalk.

Send us a textDr. Laiya Carayannopoulos & Dr. Mike Fralick connect to bring you another crossover episode, this time covering new studies on therapies for bronchiectasis and posterior circulation stroke. Take a listen and let us know what you think! Do you ever feel like you can't get ahead of charting? Freed AI has an AI driven scribe for you! You can try Freed for free right now by going to getfreed.ai. Listeners can use the INTERN50 code for $50 off their first month!Support the show

Send us a textWelcome back Rounds Table Listeners! We are back today with our Classic Rapid Fire Podcast. This week, Dr. Mike Fralick and special guest Dr. Laiya Carayannopoulos from the Intern at Work Podcast and our Medicine Pods collaboration discuss two recent papers: the use of brensocatib (a DPP-1 inhibitor) to treat bronchiectasis, and the effect of alteplase administered 4.5 to 24 hours after stroke in patients with mild posterior circulation stroke who did not receive thrombectomy. Two papers, here we go!Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (0:00 – 12:46)Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours (12:47 – 24:55)And for the Good Stuff (24:56 – 26:08):Medicine Pods qMonthly newsletter Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods

Interview with Steven J. Warach, MD, PhD, author of Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

Interview with Steven J. Warach, MD, PhD, author of Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

In this standout episode of Next Steps 4 Seniors: Conversations on Aging, we’re bringing back an audience favorite: our eye-opening interview with Nurse Practitioner Liz Jackson from Henry Ford Hospital. Liz breaks down the B.E.F.A.S.T. method for spotting stroke symptoms early, dives into the different types of strokes, and explains why timing is everything when it comes to treatment. We also tackle the red flags of heart attacks, the sneaky signs of vascular disease (yes, even leg cramping!), and how managing conditions like high blood pressure and diabetes can be game-changers. Early detection = lives saved. This episode is packed with info that could protect you or someone you love. Listen now on your favorite podcast platform! Follow us on Facebook and Instagram @ConversationsOnAging Visit nextsteps4seniors.com and our foundation at nextsteps4seniorsfoundation.org Questions or ideas? Call 248-651-5010 or email hello@nextsteps4seniors.com Sponsorship inquiries: marketing@nextsteps4seniors.com Sponsored by Aeroflow Urology: You could qualify to receive incontinence supplies at no cost through insurance—discreetly delivered to your door. Visit aeroflowurology.com/ns4s to check eligibility. (*Some exclusions apply.)Learn more : https://nextsteps4seniors.com/See omnystudio.com/listener for privacy information.

Dr. Dan Ackerman and Dr. Phillip Ferdinand discuss the impact smoking has on stroke risk.  Show reference: https://www.neurology.org/doi/10.1212/WN9.0000000000000003 

Dr. Dan Ackerman talks with Dr. Phillip Ferdinand about the association between smoking and young cryptogenic ischemic stroke. Read the related article in Neurology® Education. Disclosures can be found at Neurology.org.

In this episode, Dr. Valentin Fuster summarizes the March 25, 2025, issue of the JACC, which focuses on advancements in electrophysiology. Highlights include groundbreaking studies on leadless pacemakers, atrial fibrillation treatments, and appropriate use criteria for cardiac devices, with key papers exploring the safety of pacemaker retrieval, the role of electrograms in ablation procedures, and long-term outcomes for left atrial appendage occlusion devices.

Dr. Tesha Monteith discusses the Headache Journal article, “Association of Migraine Treatments with Reduced Ischemic Stroke Risk: Evidence from Two Large-Scale Real-World Data Analyses.” Show reference:  https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14918

Dr. BJ Hicks and Dr. Aaron Shoskes discuss the rising incidence of ischemic stroke in young adults. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000213447   

Dr. BJ Hicks talks with Dr. Aaron Shoskes about the rising incidence of ischemic stroke in young adults. Read the related article in Neurology®. Disclosures can be found at Neurology.org.

One month after ischemic stroke: Tony's journey reveals real recovery challenges, inspiring rehab tips, and key support for true healing progress! The post One Month After Ischemic Stroke: A Survivor's Guide to Recovery and Resilience appeared first on Recovery After Stroke.

In this episode of Next Steps 4 Seniors: Conversations on Aging, we sit down with Nurse Practitioner Liz Jackson from Henry Ford Hospital to discuss life-saving information on strokes, heart attacks, and vascular health. We break down the B.E.F.A.S.T. method for identifying stroke symptoms early, explore the different types of strokes, and highlight the urgency of seeking immediate medical attention. Elizabeth also shares insights on recognizing heart attack warning signs, managing key risk factors like high blood pressure and diabetes, and understanding how leg cramping may indicate vascular disease. Early detection and fast action can save lives—tune in to learn how you can protect yourself and your loved ones.

Welcome back Rounds Table Listeners!We are back today with a solo episode with Dr. Mike Fralick!This week, he will discuss a paper exploring the role of intravenous thrombolytic therapy in patients with minor ischemic stroke and intracranial vessel occlusion. Here we go!Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open-label, phase 3 superiority trial (0:00 – 6:18).And for the Good Stuff:Trial Files (6:18 – 7:59).Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePodsDo you ever feel like you can't get ahead of charting? Freed AI has an AI driven scribe for you! You can try Freed for free right now by going to getfreed.ai. Listeners can use the INTERN50 code for $50 off their first month!

Commentary by Dr.  Jian'an Wang

Moderator: Prof. José Ferro (Lisbon, Portugal)Guests: Saša Filipović (Belgrade, Serbia), Charlotte Lens (Leuven, Belgium) In this episode, first, join Ferro and Filipović as they discuss updated consensus recommendations from the COVID Task Force on managing chronic neurological conditions during and after COVID-19, covering treatment strategies, vaccination guidance, and approaches to long COVID care. Then, join Ferro and Lens as they explore research on optimizing ischemic stroke care, focusing on quality improvement, patient-reported outcomes and experiences, and insights from Lens' paper on ischemic stroke guidelines and their applicability across diverse healthcare settings. Please find the papers discussed in the episode here:• Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers — An updated European Academy of Neurology consensus statement• From guidelines to clinical practice in care for ischaemic stroke patients: A systematic review and expert opinion

Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel, MD, PhD, of Erasmus University Medical Center discusses this and more with JAMA Deputy Editor Christopher C. Muth, MD. Related Content: Intra-Arterial Thrombolytics During Thrombectomy for Ischemic Stroke—End of the Story or a New Beginning? Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke Intra-Arterial Urokinase After Endovascular Reperfusion for Acute Ischemic Stroke

مروری بر کاربردهای ترومبولیتیک در سکته‌ی مغزی ایسکمیک

Thrombectomy for acute ischaemic stroke has undergone great advances in the last decade, but the expertise and technology is restricted to tertiary hospitals. Outside of large metropolitan centres, thrombolytic treatment can buy a patient time, but for almost 30 years the first line agent has remained unchanged. Alteplase is an analog of the human tissue plasminogen activator which activates plasmin to dissolve fibrin blood clots. For many years it was assumed that alteplase should be administered within 3 hours of symptom onset, thus it was a big deal when in 2008, research showed that that window could be safely broadened out to four and a half hours.Today's guests have over the intervening years been pushing the envelope even further, in an effort to help the more than two thirds of stroke patients who present after that threshold. In this podcast, Professors Bruce Campbell and Mark Parsons discuss a trial of the relatively novel agent, tenecteplase. The publication in the New England Journal of Medicine showed that tenecteplase could improve patient outcomes even if administered up to 24 hours out from a large vessel occlusion. The researchers explain the steps that led up to their study, and the importance of perfusion imaging to identify candidates with salvageable brain tissue. Key ReferenceTenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy [NEJM. 2024]GuestsDr Duncan Austin PhD FRACP MRCP (Cabrini Health) Professor Bruce Campbell PhD FRACP (Cabrini Health; Royal Melbourne Hospital; University of Melbourne) Professor Mark Parsons PhD FRACP, FAAHMS (Sydney Neurointerventional Specialists; Consulting in Neurology, Maitland). ProductionProduced by Mic Cavazzini DPhil. Music licenced from Epidemic Sound includes ‘Things to Sort Out' by Walt Adams and ‘the Appalachian Trail' by Hunter Quinn. Image produced and copyrighted by RACP.Editorial feedback kindly provided by RACP physicians Stephen Bacchi, Aidan Tan, Courtney Dowd, Saion Chaterjee and David Arroyo.  Please visit the Pomegranate Health web page for a transcript and supporting references.Login to MyCPD to record listening and reading as a prefilled learning activity. Subscribe to new episode email alerts or search for ‘Pomegranate Health' in Apple Podcasts, Spotify,Castbox or any podcasting app.

Discover how a near-death ischemic stroke caused by hypertrophic cardiomyopathy led to an extraordinary recovery journey filled with resilience. The post Surviving an Ischemic Stroke: Roderick Jefferson's Journey with Hypertrophic Cardiomyopathy and Recovery appeared first on Recovery After Stroke.

In the October 8, 2024, issue of JACC, Dr. Casper Bonison and colleagues present a study on the risks of ischemic stroke recurrence after PFO closure, revealing that while the four-year risk remains higher than the general population, it mirrors clinical trial findings. They emphasize the importance of careful patient selection and the need for further research into closure techniques and associated stroke risk factors.

Fred shares his story of surviving an ischemic stroke, heart attacks, and arthritis, focusing on resilience, recovery, and overcoming adversity. The post Surviving Ischemic Stroke, Heart Attacks, and Arthritis: Fred's Story of Resilience and Recovery appeared first on Recovery After Stroke.

Cerebral Venous Sinus Thrombosis: Symptoms and Causes Cerebral venous sinus thrombosis (CVST) is a rare but serious condition characterized by the formation of a blood clot in the dural venous sinuses, which drain blood from the brain. Understanding the symptoms and causes of CVST is crucial for timely diagnosis and treatment. Understanding Cerebral Venous Sinus […] The post Healing and Hope: Jenna Muscat's Ischemic Stroke Recovery appeared first on Recovery After Stroke.

Watch young stroke survivor Neetu Mehra's inspiring journey from ischemic stroke at 44 to resilience and recovery. Click to hear her powerful story! The post Young Stroke Survivor Neetu's Ischemic Stroke at 44: A Powerful Story of Recovery and Resilience appeared first on Recovery After Stroke.

Commentary by Dr. Candice Silversides

Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss recent trials presented at the European Stroke Organization Conference. Show references:  Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy  Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III) Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE) Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Andy Southerland talks with Dr. Seemant Chaturvedi about recent trials presented at the European Stroke Organization Conference. Show references:  Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy  Rationale and Design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III) Colchicine for Prevention of Vascular Inflammation in Non-CardioEmbolic Stroke (CONVINCE) Intensive Ambulance-Delivered Blood- Pressure Reduction in Hyperacute Stroke This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be found at Neurology.org.

It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.

Management of stroke due to large vessel occlusion (LVO) has undergone unprecedented change in the past decade. Early identification and aggressive treatment are important in mitigating negative effects on patients' prognoses. In this episode, Allison Weathers, MD, FAAN, speaks with T. M. Leslie-Mazwi, MD, author of the article “Neurocritical Care for Patients With Ischemic Stroke,” in the Continuum June 2024 Neurocritical Care issue. Dr. Weathers is a Continuum® Audio interviewer and an associate chief medical information officer at Cleveland Clinic in Cleveland, Ohio. Dr. Leslie-Mazwi is a professor and chair in the department of neurology at the University of Washington in Seattle, Washington. Additional Resources Read the article: Neurocritical Care for Patients With Ischemic Stroke Subscribe to Continuum: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Transcript Full transcript available

Braydon Dymm, MD, is a board-certified neurologist and accomplished physician who specializes in cerebrovascular disease and stroke care.After graduating summa cum laude from the University of Detroit Mercy and earning his medical degree from Wayne State University School of Medicine, he completed his neurology residency at Michigan Medicine. Dr. Dymm recently finished an advanced fellowship in cerebrovascular neurology at Duke University Hospital. He has made significant research contributions with publications in respected journals like Neurology and Stroke. Currently, Dr. Dymm serves as a neurohospitalist in the Department of Neurology at Charleston Area Medical Center.His passion for advancing stroke care and medical education has established him as an emerging leader in the field. In this episode, we cover:The differences between ischemic and hemorrhagic strokes, including causes and symptoms.The critical of recognizing stroke symptoms quickly using the BFAST mnemonic.Gender disparities in stroke incidence, with a focus on why women are more affected and have worse outcomes.The role of high blood pressure and cholesterol in stroke risk and prevention strategies.The effectiveness of exercise, diet, and stress management in reducing stroke risk.Advances in stroke treatment, including the transition from TPA to tenecteplase for quicker administration.The potential for new technologies, like continuous blood pressure monitors, to improve stroke prevention.Sign up to The Neuro Athletics Newsletter: https://bit.ly/3ewI5P0Connect with BraydonTwitter: https://x.com/BraydonDymmMy Socials:Instagram: https://www.instagram.com/louisanicola_/Twitter : https://twitter.com/louisanicola_Sponsors for today's episode:Momentous - Use code NEURO to get 20%  off your first subscription order - code NEURO:  https://www.livemomentous.com/Inside Tracker - Use code LOUISA20 for 20% off - https://insidetracker.com/louisaZocDoc- Use code NEURO - https://www.zocdoc.com/neuro(00:00) Preview and Intro(00:36) Introducing Dr. Braydon Dymm(01:08) Gender Disparities in Stroke?(02:28) Pathology of Ischemic Stroke(06:29) Small Vessel Strokes(09:56) Alzheimer's as Vascular Dementia(11:18) Managing Blood Pressure and Cholesterol(13:15) Role of Exercise in Stroke Prevention(14:22) Resistance Training and Dementia Prevention(18:13) Golden Hour in Stroke Treatment(20:07) Recognizing Stroke Symptoms with BFAST(24:47) Anticoagulants vs. Antiplatelets(25:56) Preventing Strokes with Blood Thinners(26:45) Hemorrhagic Strokes(29:36) Medication Differences for Stroke Types(32:58) Gender Differences in Stroke Outcomes(33:04) Challenges of DeThe Neuro Athletics Newsletter Instagram: @louisanicola_Twitter : @louisanicola_YouTube: @Louisa NicolaThe Neuro Experience Podcast is proud to have hosted: Dr Andrew Huberman, Dr Gabrielle Lyon, Dr Layne Norton, Thomas DeLauer, Shawn Stevenson, Dr. Rocio Salas-Whalen, Saad Alam, Uma Naidoo, Dr. Lanna Cheuck, Angela Lee Pucci, Jillian Turecki, Dr. Jordan Feigenbaum, Dr. Darren Candow, Dr. Sue Varma, Evy Poumpouras, Dr Casey Means, Renee Deehan, Dr Chris Palmer, Dr Charles Brenner.

Interview with Urs Fischer, MD, MSc, author of Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation

Interview with Urs Fischer, MD, MSc, author of Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation

Shane Duffiney was in a car crash that damaged the blood vessels in his neck causing an ischemic stroke at 42 years of age. The post Ischemic Stroke Recovery Story – Shane Duffiney appeared first on Recovery After Stroke.

Symptoms of stroke – weakness, facial droop, slurred speech. vision loss, vertigo, ataxia, confusion or changes to mental status.   The “typical” stroke workup – blood glucose level, CTH non-con, CTA head/neck, CT Perfusion, CBC BMP Troponin EKG CXR and Coags.  Common stroke mimics – hypoglycemia, drug/alcohol intoxication, Bell's palsy, aortic dissection, complex migraines, and […]

Commentary by Dr. Candice Silversides

Bear Herbert is a stroke survivor with speech challenges and surreal out-of-body experiences, offering unique insights into his journey. The post Multiple Ischemic Stroke Recovery – Bear Herbert appeared first on Recovery After Stroke.

Amber Corker discovered that her ischemic stroke may have been caused by a gene mutation that causes sticky blood. The post Ischemic Stroke and MTHFR Gene Mutation – Amber Corker appeared first on Recovery After Stroke.

Blood clots, legitimate concern about blood clots, and well-honed knowledge about blood clots are all part of our profession's requirements for safe practice, right? And over the years I've been doing I Have a Client Who . . ., I've received dozens of stories about blood clots in one context or another. Today, we'll look at yet another: a condition called Factor Five Leiden.   Resources:    Pocket Pathology: https://www.abmp.com/abmp-pocket-pathology-app   CE class, "A Doctor's Note is Not Good Enough, and what is better".   Chronic Venous Insufficiency - an overview | ScienceDirect Topics (no date). Available at: https://www.sciencedirect.com/topics/medicine-and-dentistry/chronic-venous-insufficiency (Accessed: 10 January 2024).   Factor V Leiden (no date). Available at: https://www.nationwidechildrens.org/conditions/factor-v-leiden (Accessed: 10 January 2024).   Ghalaut, P.S. et al. (2014) ‘Ischemic Stroke in a Patient with Heterozygous Factor V Leiden Mutation: An Uncommon Association', Indian Journal of Hematology & Blood Transfusion, 30(Suppl 1), pp. 335–337. Available at: https://doi.org/10.1007/s12288-014-0392-2.   Jehangir, W. et al. (2014) ‘Treatment for Factor V Leiden, Stuck Between a Rock and a Hard Place: A Case Report and Review of Literature', Journal of Hematology, 3(2), pp. 43–45. Trani, J.L. and Lawson, J.H. (2007) ‘5 - HYPERCOAGULABLE STATES ASSOCIATED WITH CHRONIC VENOUS INSUFFICIENCY', in J.J. Bergan and C.K. Shortell (eds) Venous Ulcers. San Diego: Academic Press, pp. 55–65. Available at: https://doi.org/10.1016/B978-012373565-2.50009-9.     Sponsors:     Anatomy Trains: www.anatomytrains.com    Zibby Media: www.zibbymedia.com   Elements Massage: www.elementsmassage.com/abmp   Susan's CBD: www.susanscbd.com     Anatomy Trains is a global leader in online anatomy education and also provides in-classroom certification programs for structural integration in the US, Canada, Australia, Europe, Japan, and China, as well as fresh-tissue cadaver dissection labs and weekend courses. The work of Anatomy Trains originated with founder Tom Myers, who mapped the human body into 13 myofascial meridians in his original book, currently in its fourth edition and translated into 12 languages. The principles of Anatomy Trains are used by osteopaths, physical therapists, bodyworkers, massage therapists, personal trainers, yoga, Pilates, Gyrotonics, and other body-minded manual therapists and movement professionals. Anatomy Trains inspires these practitioners to work with holistic anatomy in treating system-wide patterns to provide improved client outcomes in terms of structure and function.                      Website: anatomytrains.com                        Email: info@anatomytrains.com             Facebook: facebook.com/AnatomyTrains                       Instagram: www.instagram.com/anatomytrainsofficial   YouTube: https://www.youtube.com/channel/UC2g6TOEFrX4b-CigknssKHA       Zibby Media is a women-led company dedicated to deepening the connections between readers, authors, and each other. We do so by offering many ways to connect—even for those who don't have time to read. Founded by Zibby Owens, author, podcaster, publisher, bookstore owner, CEO, and mother of four, Zibby Media includes a publishing house, a magazine, podcasts, retreats, classes, a book club, salon events, and an independent bookstore with frequent author events. If you have ever loved a book, you're in the right place.   Learn more at zibbymedia.com Follow us on instagram: https://www.instagram.com/zibbybooks/?hl=en Listen to the podcast @momsdonthavetimetoreadbooks Read the magazine @zibbymag   Founded by a massage therapist for massage therapists, the Elements Massage brand is a network of independently-owned and operated studios dedicated to changing lives--including yours!  The Elements Massage brand believes massage therapists deserve a supportive team, business and marketing resources, and the chance to learn as much as they want, so many Elements Massage studios offer and reimburse continuing education on an ongoing basis. It's no surprise Elements Massage therapist and client satisfaction leads the industry. That's because from day one, the brand has kept an unmatched commitment to deliver the best therapeutic massage experiences possible for both clients and massage therapists. Elements Massage studios expects the best. So should you. If this sounds like a fit, reach out. Studios are  hiring!    Website: https://elementsmassage.com/ABMP Facebook: https://www.facebook.com/elementsmassage Instagram: https://www.instagram.com/elementsmassage Youtube: https://www.youtube.com/channel/UCXLHkAYMgmA6_MJ8DSEZm-A   Disclaimer: Each Elements Massage® studio is independently owned and operated. Franchise owners (or their designated hiring managers) are solely responsible for all employment and personnel decisions and matters regarding their independently owned and operated studios, including hiring, direction, training, supervision, discipline, discharge, compensation (e.g., wage practices and tax withholding and reporting requirements), and termination of employment. Elements Therapeutic Massage, LLC (ETM) is not involved in, and is not responsible for, employment and personnel matters and decisions made by any franchise owner. All individuals hired by franchise owners' studios are their employees, not those of ETM. Benefits vary by independently owned and operated Elements Massage® studios. Elements Massage® and Elements Massage + design are registered trademarks owned by ETM.     Founded in 2017, Susan's CBD is a woman-owned business that manufactures high-quality, high-milligram CBD and CBG massage products for the massage and wellness industry. Located in Boulder, Colorado, we handcraft our massage and topical products using all-natural ingredients and effective amounts of hemp CBD because we believe milligrams matter. Elevate your client's experience and build your practice by using our wide range of massage and topical products. Licensed massage therapists can try eight different CBD and CBG massage products with our free sample pack (one per customer). Contact us today by visiting www.susanscbd.com and clicking on the Professional Pricing tab to get your free sample pack! Licensed therapists also receive 50 percent off retail pricing with a wholesale login.   Website: www.susanscbd.com Email: info@susanscbd.com Instagram: www.instagram.com/susanscbd   Host Bio:                    Ruth Werner is a former massage therapist, a writer, and an NCBTMB-approved continuing education provider. She wrote A Massage Therapist's Guide to Pathology, now in its seventh edition, which is used in massage schools worldwide. Werner is also a long-time Massage & Bodywork columnist, most notably of the Pathology Perspectives column. Werner is also ABMP's partner on Pocket Pathology, a web-based app and quick reference program that puts key information for nearly 200 common pathologies at your fingertips. Werner's books are available at www.booksofdiscovery.com. And more information about her is available at www.ruthwerner.com.     

Abdul Wahed Hassan is recovering well from an Ischemic Stroke when he was 32 which was caused by a blood clotting disorder. The post Understanding Factor V Leiden: Causes, Symptoms, and Management appeared first on Recovery After Stroke.

The Future of Cardiac Monitoring and Anticoagulation After Ischemic Stroke and TIA w/ Luciano A. Sposato, MD MBA FRCPC Professor of Neurology, Western University Host: Jacob Sambursky, MD Welcome back to Stroke Busters, a podcast presented by the Institute for Stroke and Cerebrovascular Disease at UTHealth Houston. On this show, we connect with leaders in stroke care, research, community, and academia. We're not just active; we're at the forefront—recognized as the first Comprehensive Stroke Center in the state and pioneers in launching the nation's first Mobile Stroke Unit. I'm Amy Quinn, Communications Director for the Stroke Institute, and proud to bring you another episode to share expert insights, groundbreaking research, and real stories from the forefront of medicine.  It's that time again for a Grand Rounds follow-up interview! Dr. Luciano Sposato, Professor of Neurology, at Western University joined us for Grand Rounds at the McGovern Medical School here in Houston, TX, and presented on The Future of Cardiac Monitoring and Anticoagulation After Ischemic Stroke and TIA.  Following his Grand Rounds presentation for trainees and students, one of our Stroke Fellows Jacob Sambursky, stuck around to ask some more in-depth questions. As always, Ideas and opinions expressed on this podcast are our own and are not a substitute for expert medical advice. Always contact your doctor before starting any program or therapy to make sure you are getting the best care, tailored to your unique situation.   UTHealth Stroke is on social media! Follow us on Twitter, LinkedIn, Instagram, and Facebook at UTHEALTHSTROKE to stay updated on upcoming episodes, and share with colleagues, friends, and family.  For updates and the latest news on the Stroke Institute, go online to uth.edu/stroke-institute

Dr Siva had an ischemic stroke while working in a hospital as a surgeon in 2017. He co authored a book about his experience. The post Surgeon Who Survived Ischemic Stroke – Dr Siva Murugappan appeared first on Recovery After Stroke.

Aimee Silverman is on the road to Ischemic Stroke Recovery after a blood clot formed in her head aged 49 The post Ischemic Stroke Recovery | Aimee Silverman appeared first on Recovery After Stroke.

In this episode, we review the role and indications of thrombolytics in acute ischemic stroke. The efficacy, safety, administration considerations, and cost between alteplase and tenecteplase are compared and contrasted. Key Concepts Alteplase (Activase) is a recombinant DNA version of human TPA (tissue plasminogen activator). Tenecteplase (TNKase) is similar to human TPA except it has three amino acid changes that result in a longer half-life and higher fibrin specificity. In patients with stroke, alteplase is given as a bolus followed by a 60-minute infusion. Tenecteplase is given as an IV bolus without the need for an infusion due to its longer half-life. Tenecteplase is at least as safe and effective as alteplase in acute ischemic stroke (with some studies showing greater benefit with tenecteplase). In patients with acute ischemic stroke who are candidates for mechanical thrombectomy, thrombolytics (with alteplase or tenecteplase) will still be given in patients who meet inclusion criteria and have no exclusion criteria. References Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [published correction appears in Stroke. 2019 Dec;50(12):e440-e441]. Stroke. 2019;50(12):e344-e418. doi:10.1161/STR.0000000000000211 Campbell BCV, Mitchell PJ, Churilov L, et al. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke. N Engl J Med. 2018;378(17):1573-1582. doi:10.1056/NEJMoa1716405 Kobeissi H, Ghozy S, Turfe B, et al. Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials. Front Neurol. 2023;14:1102463. Published 2023 Jan 23. doi:10.3389/fneur.2023.1102463

Commentary by Dr. Valentin Fuster

Eric Jackson has been living with the aftermath of Ischemic stroke and Aphasia for 10 years now. Listen to how far he has come and how he manages his condition now. The post Aphasia Recovery and Ischemic Stroke Recovery, 10 Years On | Eric Jackson appeared first on Recovery After Stroke.

You just graduated from nursing school, and now you're working as a nurse in the emergency department. The EMTs bring in a 26 year old female with generalized weakness of the left lower and upper extremities, and a sudden headache. What do you do? Can you complete all 5 critical actions, or will you carry out a dangerous action? Learn the most important things to do for stroke patients as a nurse.Check out TrueLearn for an NCLEX program that perfectly integrates with Picmonic!Get 30% off a Picmonic subscription, or just get one free Picmonic every day!

On this episode, we are joined by Dr. Brian Gilbert, PharmD, BCCCP, FCCM, FNCS, to compare and contrast alteplase (tPA) versus tenecteplase (TNK-tPA) in the setting ischemic stroke. Brian is an emergency medicine clinical pharmacy specialist at Wesley Medical Center. He also serves as the PGY-2 critical care pharmacy residency program director and as an adjunct assistant clinical professor at the University of Kansas School of Pharmacy.  Thanks for listening! We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:  www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx  This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.

Today we have a special guest, Dr. Joel Topf, board-certified nephrologist and medical educator extraordinaire. Our listeners will likely recognize Dr. Topf from his prolific tweeting @Kidney_boy, as well as his numerous appearances on the Curbsiders podcast. He is a co-founder of the NephJC on Twitter, and host and founder of the NephJC podcast Freely Filtered. He is also host of the podcast Channel Your Enthusiasm, a deep dive monthly recap of the nephrology textbook Clinical Physiology of Acid Base and Electrolyte Disorders by Dr. Burton Rose (who, incidentally, is the creator of the original UpToDate). Dr. Topf wrote his own book on fluids, electrolytes and acid-base homeostasis.  He's the co-editor for the fourth edition of Nephrology Secrets and the first edition of The Handbook of Critical Care Nephrology. Dr. Topf joined us to talk about a new paper he co-authored on osmotic demyelination syndrome and hyponatremia. I'm also joined by Dr. Mita Hoppenfeld, hospitalist at the University of Utah, to talk about a new DOAC vs warfarin trial in On-X aortic valves, whether it's better to avoid hypertension or hypotension around time of surgery, and the diagnostic accuracy of CT abdomen scans without contrast. Check it out! Osmotic Demyelination and HyponatremiaApixaban vs Warfarin for On-X Aortic ValvePerioperative Blood Pressure Strategies Diagnostic Accuracy of CT Abdomen Without ContrastMusic from Uppbeat (free for Creators!):https://uppbeat.io/t/soundroll/dopeLicense code: NP8HLP5WKGKXFW2R

Today we talked about the ischemic stroke, which is one of two strokes with the ladder been the hemorrhagic stroke. --- Send in a voice message: https://podcasters.spotify.com/pod/show/thepublicsafetyguru/message